Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs [Protocol] / L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN in Cochrane Database of Systematic Reviews, n°1 (2016)  

Donner un avis [article]  inCochrane Database of Systematic Reviews > n°1 (2016) . - CD012021 ; 15 p. Titre : Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs [Protocol] Type de document : Périodique Auteurs : L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN Année de publication : 2016 Article en page(s) : CD012021 ; 15 p. Langues : Anglais (eng) Mots-clés : Thésaurus TOXIBASE ECHANGE DE SERINGUES ; TRAITEMENT DE MAINTENANCE ; REDUCTION DES RISQUES ; EFFICACITE ; HEPATITE ; USAGER ; INTERVENTION Discipline : TRA Traitement et prise en charge / Treatment and care Résumé : This is the protocol for a review and there is no abstract. The objectives are as follows: 1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of HCV infection among people who inject drugs (PWID). 2. To assess the effect of OST alone on the incidence of HCV infection among PWID. RESEARCH QUESTIONS: 1. How effective are needle/syringe programmes (NSP) with and without the use of OST for reducing HCV incidence among PWID? 2. How effective is OST alone for reducing HCV incidence among PWID? 3. How does the effect of NSP and OST vary according to duration of treatment (i.e. for NSPs weekly attendance versus monthly)? 4. How does the effect of NSP vary according to the type of service (fixed site versus mobile; high coverage versus low coverage)? 5. How does the effect of OST vary according to the dosage of OST, type of substitution used and adherence to treatment? Domaine : Drogues illicites / Illicit drugs Sous-type de document : Revue de la littérature / Literature review Affiliation : Centre for Research on Drugs and Health Behaviour, Department of Social and Environmental Health Research, London School of Hygiene and Tropical Medicine, London, UK Lien : http://dx.doi.org/10.1002/14651858.CD012021 Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=77326 [article]

Titre suivant

• Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs [Intervention review] / L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN in Cochrane Database of Systematic Reviews, n°9 (2017)

- voir aussi

• Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis / L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN in Addiction, Vol.113, n°3 (March 2018)

Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England / V. HOPE in BMC Infectious Diseases, Vol.8, n°120 (18 September 2008)  

Donner un avis [article]  inBMC Infectious Diseases > Vol.8, n°120 (18 September 2008) . - 1-8 Titre : Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England Type de document : Périodique Auteurs : V. HOPE ; J. KIMBER ; P. VICKERMAN ; M. HICKMAN ; F. NCUBE Année de publication : 2008 Article en page(s) : 1-8 Langues : Anglais (eng) Mots-clés : Thésaurus Géographique ROYAUME-UNI Thésaurus TOXIBASE INJECTION ; VOIE D'ADMINISTRATION ; INFECTION ; ENQUETE ; USAGER ; COUT ; ABCES ; ACCES AUX SOINS ; HEPATITE Discipline : MAL Maladies infectieuses / Infectious diseases Résumé : BACKGROUND: Injection site infections among injecting drug users (IDUs) have been associated with serious morbidity and health service costs in North America. This study explores the frequency, factors and costs associated with injection site infections among IDUs in England. METHODS: Unlinked-anonymous survey during 2003/05 recruiting IDUs from community settings at seven locations across England. Self-reported injecting practice, symptoms of injection site infections (abscess or open wound) and health service utilisation data were collected using a questionnaire, participants also provided dried blood spot samples (tested for markers blood borne virus infections). Cost estimates were obtained by combining questionnaire data with information from national databases and the scientific literature. RESULTS: 36% of the 1,058 participants reported an injection site infection in the last year. Those reporting an injection site infection were more likely to be female and aged over 24, and to have: injected into legs, groin, and hands in last year; injected on 14 or more days during the last four weeks; cleaned needles/syringes for reuse; injected crack-cocaine; antibodies to hepatitis C; and previously received prescribed substitute drug. Two-thirds of those with an injection site infection reported seeking medical advice; half attended an emergency department and three-quarters of these reported hospital admission. Simple conservative estimates of associated healthcare costs range from pound 15.5 million per year to as high as pound 30 million; though if less conservative unit costs assumptions are made the total may be much higher (pound 47 million). The vast majority of these costs are due to hospital admissions and the uncertainty is due to little data on length of hospital stays. CONCLUSION: Symptoms of injection site infections are common among IDUs in England. The potential costs to the health service are substantial, but these costs need more accurate determination. Better-targeted interventions to support safer injection need to be developed and evaluated. The validity of self-reported symptoms, and the relationship between symptoms, infection severity, and health seeking behaviour require further research. Domaine : Drogues illicites / Illicit drugs Refs biblio. : 39 Affiliation : Centre for Infections, Health Protections Agency, London. Royaume-Uni. United Kingdom. Centre Emetteur : 13 OFDT Cote : A03876 Lien : http://www.biomedcentral.com/1471-2334/8/120 Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=52026 [article]

Hepatitis C infection among recent initiates to injecting in England 2000-2008: Is a national hepatitis C action plan making a difference? / V. HOPE ; J. V. PARRY ; A. MARONGUI ; F. NCUBE in Journal of Viral Hepatitis, Vol.19, n°1 (January 2012)  

Donner un avis [article]  inJournal of Viral Hepatitis > Vol.19, n°1 (January 2012) . - 55-64 Titre : Hepatitis C infection among recent initiates to injecting in England 2000-2008: Is a national hepatitis C action plan making a difference? Type de document : Périodique Auteurs : V. HOPE ; J. V. PARRY ; A. MARONGUI ; F. NCUBE Année de publication : 2012 Article en page(s) : 55-64 Langues : Anglais (eng) Mots-clés : Thésaurus Géographique ANGLETERRE ; ROYAUME-UNI Thésaurus TOXIBASE HEPATITE ; INFECTION ; INJECTION ; INITIATION ; PREVALENCE ; DEPISTAGE ; INCIDENCE ; ENQUETE Discipline : MAL Maladies infectieuses / Infectious diseases Résumé : Around 80% of hepatitis C virus (HCV) infections in England are among injecting drug users (IDUs). The HCV Action Plan launched in 2004 includes targets to reduce HCV prevalence in recent initiates (those starting injecting in the preceding 3 years), and to increase HCV voluntary confidential testing (VCT). The Action Plan’s impact is examined using surveillance data from recent initiates participating in an annual survey of IDUs in contact with specialist services across England, 2000-2008. Participants provided an oral fluid sample (tested for anti-HCV) and completed a short questionnaire (including HCV VCT and result of last test). Overall, anti-HCV prevalence among the recent initiates was 18% (619/3463); in 2004, it was 20% (59/291), other than being lower in 2000 [11%, 73/672, adjusted odds ratio (AOR) = 0.63 95%CI 0.42-0.93] there was no change over time. Prevalence increased with age; was higher among those ever imprisoned, using a needle exchange, and having a HCV VCT; and varied by region. Overall, 42% (1460) had ever had a HCV VCT; in 2004 uptake was 45% (130/291) having increased from 26% (175/672, AOR = 0.57 95%CI 0.42-0.77) in 2000, and it rose to 62% (197/320, AOR = 2.12 95%CI 1.50-2.99) in 2008. The proportion of anti-HCV-positive IDUs aware of their infection was higher in 2006-2008 than in earlier years. The HCV Action Plan has probably helped increase recent initiates’ uptake of HCV VCT and the proportion of those diagnosed with HCV infection. However, its impact on HCV transmission is unclear. There is a need to reinvigorate, and improve coverage of, interventions to prevent HCV transmission. Domaine : Drogues illicites / Illicit drugs Refs biblio. : 46 Affiliation : Centre for Infections, Health Protection Agency, London, UK Lien : http://dx.doi.org/10.1111/j.1365-2893.2010.01415.x Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=68753 [article]

Human immunodeficiency virus among people who inject drugs: Is risk increasing in Europe? / D. HEDRICH ; E. KALAMARA ; O. SFETCU ; A. PHARRIS ; A. NOOR ; L. WIESSING ; V. HOPE ; M. J. VAN DE LAAR in Eurosurveillance, Vol.18, n°48 (28 November 2013)  

Donner un avis [article]  inEurosurveillance > Vol.18, n°48 (28 November 2013) . - Art. 20648 Titre : Human immunodeficiency virus among people who inject drugs: Is risk increasing in Europe? Type de document : Périodique Auteurs : D. HEDRICH ; E. KALAMARA ; O. SFETCU ; A. PHARRIS ; A. NOOR ; L. WIESSING ; V. HOPE ; M. J. VAN DE LAAR Année de publication : 2013 Article en page(s) : Art. 20648 Langues : Anglais (eng) Mots-clés : Thésaurus Géographique EUROPE ; UNION EUROPEENNE Thésaurus TOXIBASE VIH ; USAGER ; INJECTION ; EVOLUTION ; PREVALENCE ; FACTEUR DE RISQUE ; CONTAMINATION Organismes OEDT Discipline : MAL Maladies infectieuses / Infectious diseases Résumé : In most European Union (EU)/European Economic Area (EEA) countries, between 2010 and 2012, reports of new human immunodeficiency virus (HIV) diagnoses among people who inject drugs have been stable or declining. HIV outbreaks in Greece and Romania, first reported in 2011, continue and economic conditions hinder provision of effective response coverage. When measured against some established thresholds, prevention coverage remains inadequate in at least one-third of EU/EEA countries. Urgent consideration to scale up prevention efforts is merited. Domaine : Drogues illicites / Illicit drugs Refs biblio. : 20 Affiliation : European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal Lien : http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20648 Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=73490 [article]

Injecting drug use in Brighton, Liverpool and London: best estimates of prevalence and coverage of public health indicators / M. HICKMAN in Journal of Epidemiology and Community Health, Vol.58 n°9 (2004)

Donner un avis [article]  inJournal of Epidemiology and Community Health > Vol.58 n°9 (2004) . - 766-771 Titre : Injecting drug use in Brighton, Liverpool and London: best estimates of prevalence and coverage of public health indicators Titre traduit : (Injection de drogues à Brighton, Liverpool et Londres : meilleure estimation de la prévalence et de la couverture des indicateurs de santé publique) Type de document : Périodique Auteurs : M. HICKMAN ; HIGGINS V. ; V. HOPE ; M. A. BELLIS ; K. TILLING ; A. WALKER ; J. HENRY Année de publication : 2004 Article en page(s) : 766-771 Présentation : tabl. Note générale : Journal of Epidemiology and Community Health, 2004, 58, (9), 766-771 Langues : Anglais (eng) Mots-clés : Thésaurus TOXIBASE INJECTION ; USAGER ; VOIE INTRAVEINEUSE ; PREVALENCE ; SANTE PUBLIQUE ; METHODE ; EPIDEMIOLOGIE DESCRIPTIVE ; ENQUETE Thésaurus Géographique ROYAUME-UNI Discipline : EPI Epidémiologie / Epidemiology Résumé : ENGLISH : Study objective: To estimate the prevalence of injecting drug use (IDU) in three cities in England and to measure the coverage of key public health indicators. Design: Capture-recapture techniques with covariate effects. Setting: Liverpool, Brighton, and 12 London boroughs, 2000/01. Participants: IDU collated and matched across five data sources -community recruited survey, specialist drug treatment, arrest referral, syringe exchange, and accident and emergency- 896 in Brighton, 1224 in Liverpool, and 6111 in London. Main results: It is estimated that in 2000/01 the number and prevalence of IDU aged 15-44 was 2300 (95%Cl 1500 to 3700) and 2.0% (95%Cl% 1.3% to 3.2%) in Brighton; 2900 (95%Cl 2500 to 5000) and 1.5% (95%Cl 1.3% to 2.6%) in Liverpool; 16 700 (95%Cl 13 800 to 21 600) and 1.2% (95%Cl 1.0% to 1.6%) in 12 London boroughs; with a prevalence of 1.7% (95%Cl 1.2% to 3.3%) in inner London. It is estimated that: less than one in four IDU are in treatment in the three areas; syringe exchange programmes covered about 25% of injections in Brighton and Liverpool and 20% in London; and that the annual opioid mortality rate among IDU was 2% in Brighton compared with less than 1% in Liverpool and London. Conclusions: Credible estimates of the prevalence of injecting drug use (and key public health indicators) can be determined using covariate capture-recapture techniques. These suggest that: targets to double the number in treatment are possible: syringe distribution should be increased; and further attention, especially in Brighton, given to reducing overdose mortality. (Review' s abstract) Note de contenu : tabl. Domaine : Drogues illicites / Illicit drugs Refs biblio. : 43 Affiliation : CRDHB, Social Science and Medicine, Imperial College, Charing Cross Campus, St Dunstans Rd, London SW6 1RQ Royaume-Uni. United Kingdom. Numéro Toxibase : 1300985 Centre Emetteur : 13 OFDT Cote : Abonnement Permalink : https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=56845 [article]

Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness / G. J. MACARTHUR ; E. VAN VELZEN ; N. E. PALMATEER ; J. KIMBER ; A. PHARRIS ; V. HOPE ; A. TAYLOR ; K. ROY ; E. ASPINALL ; D. GOLDBERG ; T. RHODES ; D. HEDRICH ; M. SALMINEN ; M. HICKMAN ; S. J. HUTCHINSON in International Journal of Drug Policy, Vol.25, n°1 (January 2014)

Permalink

Mapping HIV-related behavioural surveillance among injecting drug users in Europe, 2008 / V. HOPE ; A. JEANNIN ; B. SPENCER ; J. P. GERVASONI ; M. J. VAN DE LAAR ; F. DUBOIS-ARBER ; ECDC HIV and STI Behavioural Surveillance Mapping Group in Eurosurveillance, Vol.16, n°36 (8 September 2011)  

Permalink

Mapping HIV/STI behavioural surveillance in Europe / F. DUBOIS-ARBER ; A. JEANNIN ; B. SPENCER ; J. P. GERVASONI ; B. GRAZ ; J. ELFORD ; V. HOPE ; F. LERT ; H. WARD ; M. HAOUR-KNIPE ; N. LOW ; M. J. VAN DE LAAR in BMC Infectious Diseases, Vol.10, n°290 (4 October 2010)  

Permalink

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis / L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN in Addiction, Vol.113, n°3 (March 2018)  

Permalink

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs [Intervention review] / L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN in Cochrane Database of Systematic Reviews, n°9 (2017)  

Permalink

Respondent driven sampling and community structure in a population of injecting drug users, Bristol, UK / H. L. MILLS ; C. COLIJN ; P. VICKERMAN ; D. LESLIE ; V. HOPE ; M. HICKMAN in Drug and Alcohol Dependence, Vol.126, n°3 (December 2012)

Permalink

Le rôle des méthodes d'évaluation rapide dans l'épidémiologie de l'usage de drogues / C. FITCH

Permalink

Sexualised drug use in the United Kingdom (UK): A review of the literature / C. EDMUNDSON ; E. HEINSBROEK ; R. GLASS ; V. HOPE ; H. MOHAMMED ; M. WHITE ; M. DESAI in International Journal of Drug Policy, Vol.55 (May 2018) 

Permalink

Shooting Up. Infections among injecting drug users in the United Kingdom 2006. An update: October 2007 / Health Protection Agency

Permalink

The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland / C. O'HALLORAN ; K. CULLEN ; J. NJOROGE ; L. JESSOP ; J. SMITH ; V. HOPE ; F. NCUBE in International Journal of Drug Policy, Vol.46 (August 2017) 

Permalink